Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?

Evaluation of COVID-19 Incidence in Patients With Preeclampsia During Pandemic

By applying polymerase chain reaction (PCR) test for Covid-19 to preeclampsia patients who applied to our hospital during the Covid-19 pandemic period, we investigated the frequency of Covid-19 related preeclampsia-like syndrome in this patient group.

The investigators studied the frequency of Covid-19 related preeclampsia-like syndrome by PCR test and lung ultrasound for Covid-19 to preeclampsia patients presenting to the instutution during the Covid-19 pandemic period. The first consecutive 100 preeclampsia patients presented to our hospital during the pandemic will be involved in our study. The primary outcome measure is to detect Covid-19 positivity among the preeclamptic pregnant women..

Inclusion Criteria:

• First consecutive 100 pregnant women presenting with preeclamptic symptoms and signs between March 15, 2020 and June 1, 2020.

Exclusion Criteria:

• The pregnancies with known diagnosis of preeclampsia before Covid-19 pandemic
• Preeclamptic patient without a Covid-19 PCR test result
• Pregnant women who does not want to participate in study or does not want their personal informations to be shared
• Pregnant women less than 18 years old and more than 40 years old are excluded